Nano-X and Understanding the Risk/Reward Spectrum
In this episode of Industry Focus: Wildcard, we are bringing healthcare back into the spotlight, as the Nano-X.ARC (NASDAQ: NNOX) digital x-ray technology is getting 510(k) clearance from the Food and Drug Administration. Then, we use the company to explore the risk/reward spectrum and the trade-off of upside versus certainty with an investment.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com


